VRAX (Virax Biolabs Group) Days Inventory : 418.23 (As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Virax Biolabs Group Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Virax Biolabs Group's Average Total Inventories for the six months ended in Mar. 2025 was $0.11 Mil. Virax Biolabs Group's Cost of Goods Sold for the six months ended in Mar. 2025 was $0.05 Mil. Hence, Virax Biolabs Group's Days Inventory for the six months ended in Mar. 2025 was 418.23.

The historical rank and industry rank for Virax Biolabs Group's Days Inventory or its related term are showing as below:

VRAX' s Days Inventory Range Over the Past 10 Years
Min: 57.63 Med: 344.01 Max: 766.5
Current: 577.4

During the past 6 years, Virax Biolabs Group's highest Days Inventory was 766.50. The lowest was 57.63. And the median was 344.01.

VRAX's Days Inventory is ranked worse than
83.49% of 642 companies
in the Biotechnology industry
Industry Median: 180.08 vs VRAX: 577.40

Virax Biolabs Group's Days Inventory increased from Mar. 2024 (193.91) to Mar. 2025 (418.23). It might indicate that Virax Biolabs Group's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. Virax Biolabs Group's Inventory Turnover for the six months ended in Mar. 2025 was 0.44.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Virax Biolabs Group's Inventory-to-Revenue for the six months ended in Mar. 2025 was 110.00.

Virax Biolabs Group Days Inventory Historical Data

The historical data trend for Virax Biolabs Group's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virax Biolabs Group Days Inventory Chart

Virax Biolabs Group Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Days Inventory

Get a 7-Day Free Trial

57.63

766.50

208.57

479.45

Virax Biolabs Group Semi-Annual Data
	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24	Mar25
Days Inventory	Get a 7-Day Free Trial						-	69.13	193.91	1,534.66	418.23

Competitive Comparison of Virax Biolabs Group's Days Inventory

For the Biotechnology subindustry, Virax Biolabs Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Virax Biolabs Group's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Virax Biolabs Group's Days Inventory distribution charts can be found below:

* The bar in red indicates where Virax Biolabs Group's Days Inventory falls into.

Save Embed

;

Save Embed

;

Virax Biolabs Group Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Virax Biolabs Group's Days Inventory for the fiscal year that ended in Mar. 2025 is calculated as

	Days Inventory (A: Mar. 2025 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Mar. 2024 )	+	Total Inventories (A: Mar. 2025 ))	/	count )	/	Cost of Goods Sold (A: Mar. 2025 )	*	Days in Period
=	( (0.06	+	0.095)	/	2 )	/	0.059	*	365
=	0.0775					/	0.059	*	365
=	479.45

Virax Biolabs Group's Days Inventory for the quarter that ended in Mar. 2025 is calculated as:

	Days Inventory (Q: Mar. 2025 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Sep. 2024 )	+	Total Inventories (Q: Mar. 2025 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2025 )	*	Days in Period
=	( (0.125	+	0.095)	/	2 )	/	0.048	*	365 / 2
=	0.11					/	0.048	*	365 / 2
=	418.23

Virax Biolabs Group (NAS:VRAX) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Virax Biolabs Group's Inventory Turnover for the six months ended in Mar. 2025 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.048	/	0.11
	=	0.44

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Virax Biolabs Group's Inventory to Revenue for the six months ended in Mar. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.11	/	0.001
	=	110.00

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Virax Biolabs Group Days Inventory Related Terms

Thank you for viewing the detailed overview of Virax Biolabs Group's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Virax Biolabs Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Virax Biolabs Group Ltd (NAS:VRAX) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bo’Ness Road Newhouse, BioCity Glasgow, London, GBR, ML1 5UH

Website

https://www.viraxbiolabs.com

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.